Tag: hugel

hugel

Latest News

Korea's Hugel to launch direct sales in bid to expand share in U.S. medical aesthetics market

Hugel, a Korean medical aesthetics company, plans to establish a direct sales organization in the United States as it aims to capture a 14 percent share of the U.S. botulinum toxin market by 2030.

2026.1.16

Hugel Chief Financial Officer Eva Huang speaks during a presentation at the 43rd J.P. Morgan Healthcare Conference in San Francisco, California, on Jan. 16. [LEE JAE-LIM]

Hugel eyes 10 percent of U.S. market after trade regulator hands it 'decisive win'

Korean aesthetic company Hugel is clear to enter the United States market after a favorable ruling by the country's trade regulator.

2025.1.17

Most popular

Hugel's botulax botulinum toxin products [HUGEL]

Preliminary U.S. trade decision favors Hugel over Medytox in Botox-related case

Kosdaq-listed Hugel prevailed over Medytox in a preliminary decision by the U.S. International Trade Commission in a dispute over a Botox-related product.

2024.6.11

GS Holdings headquarters in Yeoksam-dong, southern Seoul [GS HOLDINGS]

GS Holdings consortium chosen as preferred bidder for Medit

A GS Holdings-Carlyle Group consortium has been selected as the preferred bidder to acquire Medit, a Yeongdeungpo-based company manufacturing 3-D dental scanners.

2022.10.25

Hugel's hyaluronic acid filler product wins sale approval in China

Hugel's hyaluronic acid filler product won sale approval from health regulators in China, the company said Tuesday.

2022.4.19

[NEWS ANALYSIS] Second Battle of the Botoxes breaks out in Korea

Botulinum toxin is at the center of another legal battle as Medytox accused Hugel of misappropriation of trade secrets.

2022.4.13

Supreme Court dismisses appeal to suspend sales of Hugel's Botox

The Supreme Court dismissed an appeal filed by the Seoul Regional Office of Food and Drug Safety in an ongoing legal row over the suspension of the sale of Hugel's botulinum toxin products, Hugel said Wednesday.

2022.4.6

Hugel can sell its botulinum toxin product in U.K.

Hugel's Letybo botulinum toxin product was approved for sale in Britain, the company said Thursday.

2022.3.24

Hugel’s Letybo wins marketing approval from Austria

Letybo, Hugel’s botulinum toxin product, won marketing approval from health regulators in Austria, the company said Tuesday.

2022.2.22

Sohn Ji-hoon, CEO of Hugel, speaks about the company’s 2022 goals during an online press conference held Friday. [HUGEL]

Hugel wants to send its botulinum toxin around the world

Hugel’s main focus for 2022 is to go global, with the goal of claiming 10 percent of the world market share for botulinum toxin in five years.

2022.2.11